Sirona Biochem (TSE:SBM) has released an update.
Sirona Biochem Corp. is advancing in the skincare market with the receipt of anti-aging serum formulations based on its GlycoProteMim™ technology from Global Beauty Consulting. These formulations are set to form the cornerstone of a new product range, with clinical trials and regulatory compliance paving the way for a planned launch in early 2025. The company is distributing samples to key stakeholders across Asia, Europe, and North America to reinforce its commitment to revolutionizing skincare through scientific innovation.
For further insights into TSE:SBM stock, check out TipRanks’ Stock Analysis page.
